← Back to headlines





FDA Panel Green-Lights Peptides, Raising Market Attention and Regulation Concerns
An FDA advisory panel recently voted to approve certain popular peptides, drawing considerable attention to their market. The decision has also sparked concerns regarding the currently unregulated supply of these products.
3 Aug, 11:00 — 3 Aug, 11:00
Related Stories

Hyundai Motor Reaches Tentative Wage Deal with Union, Averting Further Strikes
8m ago

Unsealed Documents Reveal Murdoch Family Succession Battle Details
11m ago

Lego Reports Double-Digit Growth, Driven by Flower Sets and Familiar Universes
16m ago

Global Markets React to Nvidia Earnings Anticipation and Geopolitical Tensions
24m ago